Claritev Corporation

Claritev Corporation raised its full-year 2026 revenue guidance to a range of $1.0 billion to $1.02 billion, reflecting 4% to 6% growth, while affirming it will deliver in excess of $100 million of bookings this year. The company also lifted its adjusted EBITDA forecast to $610 million to $620 million with margins of approximately 61%, and increased its free cash flow guide by $5 million to a new range of $5 million to $15 million. Second-quarter revenue rose 6.6% year-over-year to $257.5 million, marking the highest quarterly revenue in 15 quarters, and adjusted EBITDA reached $155.8 million, representing 60.5% of revenue. Bookings momentum was strong, with $30 million of annual contract value booked in the quarter, pushing first-half bookings above the full-year 2025 total of $67 million, and the active pipeline exceeded $300 million, up 50% with greater than 3x coverage. Management highlighted the TPA vertical as the largest contributor to second-quarter bookings, with several seven-figure deals, and expects the segment to account for roughly 30% of total new bookings this year, second only to the payer segment.

Sun Life U.S. and Claritev are collaborating to bring more efficiency to supplemental health coverage for self-funded employers. Claritev's machine-learning technology reviews medical claims to identify employees eligible for critical illness, accident, and hospital indemnity benefits, enabling Sun Life to proactively notify them and accelerate payments. The solution is available to any self-funded employer offering Sun Life supplemental health coverage, regardless of whether they are a stop-loss client, and is now open for quoting for policies effective January 1, 2027, and later, though it is not available in New York. Sun Life U.S. serves approximately 48 million Americans, while Claritev supports over 750 healthcare payers and more than 100,000 employers.